key: cord-0283040-wbipiri2 authors: Wu, P. C.; McPherson, L.; Lambert, S. B.; Wnukowski-Mtonga, P.; Lennox, N. G.; Ware, R. S. title: Comparing Interventions Aimed at Improving Influenza Vaccination Coverage Among Vulnerable Populations: A Systematic Review and Meta-Analysis Protocol date: 2021-03-11 journal: nan DOI: 10.1101/2021.03.08.21253172 sha: 9501f0be5e986dd73acd657e4a31ec36e96c47e6 doc_id: 283040 cord_uid: wbipiri2 Background Influenza is a major contributor to global disease burden. Vaccination recommendations specifically target populations at increased risk of serious influenza sequelae. The aim of this study is to conduct a systematic review and meta-analysis to evaluate the effectiveness of different quality improvement interventions to increase vaccination rates in high-risk populations. Methods Randomized and nonrandomized studies with concurrent control groups will be identified. Interventions to increase vaccination rates will be categorized by strategy type. Overall intervention effects will be calculated using random effects models. Study quality will be assessed using a modified Cochrane Risk of Bias tool. Influenza is a vaccine-preventable acute respiratory infection directly responsible for three to five million cases of severe illness annually, resulting in 250,000 to 500,000 deaths. 1 The financial burden of influenza and its sequelae are substantial: estimates from the United States are of annual direct losses of US$10.4 billion as a direct consequence of influenza, with an additional US$16.3 billion lost in sick days and productivity. 2 Influenza disproportionately affects infants, young children, adults aged 65 years or older, pregnant women, immunocompromised individuals, First Nations peoples, and those suffering from chronic disease; all of whom are at risk of experiencing increased morbidity and mortality due to influenza. 3, 4 Current health care guidelines in most developed nations recommend annual vaccination for the aforementioned high-risk groups. In order to maximize the benefits these populations derive from immunization, the US Department of Health and Human Services has launched the Healthy People 2020 initiative in order to improve preventive health care. 5 The initiative aims to increase influenza vaccination rates for various high-risk groups to targets ranging from 70 to 90 percent. Vaccination coverage rates for vulnerable populations have been rising substantially over the past two decades in most developed countries. In Australia, between 1 March and 19 April 2020, over 2.1 million influenza vaccinations were administered and recorded in the Australian Immunisation Register compared to 624,000 at the same time in 2019 and 235,000 in 2018 6 , as government, GPs and other vaccine providers encouraged people to get vaccinated to avoid the combination of COVID-19 and influenza which could be life threatening, but inconsistent and even decreasing trends in coverage have been recently reported in the U.S, 7 Europe 8 and Canada, 9 indicating that coverage rates still fall short of the goals proposed by the Healthy People 2020 initiative. In developed nations, the majority of influenza vaccinations take place in community settings. community-based primary care centers remain the most effective way to promote health to the public, and various outreach initiatives have been trialled in the community with the aim to increase influenza vaccination coverage in vulnerable populations. Ompad et al. 10 previously reviewed over 50 studies examining interventions directed towards high-risk populations, and found the majority of interventions did not result in vaccination rates that met the Healthy People 2010 goals. Moreover, the study did not perform statistical analyses to evaluate the effectiveness of each intervention, and did not focus on community-settings. A previous systematic review and meta-analysis by Lau et al. 11 found that various quality improvement . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 11, 2021. ; https://doi.org/10.1101/2021.03.08.21253172 doi: medRxiv preprint interventions were effective in increasing influenza and pneumococcal vaccination coverage in elderly adults, but did not examine intervention effects on other vulnerable populations, and did not focus exclusively on primary care interventions. The aim of this study is to systematically evaluate, compare, and analyze the effectiveness of different intervention strategies for improving influenza vaccination coverage, with the goal of identifying the most effective strategies to improve vaccination coverage among vulnerable populations in the community. This review protocol will follow the guidelines for the Preferred Reporting Items for Systematic Reviews and Metanalysis (PRISMA) 12 and is reported here using the Guidance notes for registering a systematic review protocol with PROSPERO provided by the Centre for Program. During this time the search strategy was developed and the publications appearing prior to December 2017 were identified, the study characteristics were recorded, and data was . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 11, 2021. ; https://doi.org/10.1101/2021.03.08.21253172 doi: medRxiv preprint extracted. After this Protocol is submitted the search will be re-run and eligible publications will be identified for inclusion in meta-analyses. Prof Robert Ware . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 11, 2021. ; https://doi.org/10.1101/2021.03.08.21253172 doi: medRxiv preprint All authors declare they have no known conflicts of interest. Which vaccination strategies are the most effective for improving influenza vaccination coverage among vulnerable populations in the community? We will identify relevant studies for synthesis using four databases (Cochrane Library via John Wiley & Sons Inc., MEDLINE via EBSCOHost, EMBASE via Elsevier, and CINAHL via EBSCOHost). Search strategies for each database were prepared by PW in consultation with other team members and a university library Information specialist. Preliminary searches were conducted using the various suggested terms to pilot the study selection process. After screening search results against eligibility criteria, modifications were made as considered necessary. The final search strategies as used in the first version of this systematic review are detailed in Appendix I. Studies will be included if they compared the effectiveness of a quality improvement intervention against a contemporaneous comparison group in a community setting. For inclusion, studies will need to report vaccination rates, be published in an English language peer-reviewed journal and involve a high-risk population living in the community. A population is defined as being high risk if it was included in the guidelines provided by the . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Strategies will be categorized based on the classification system proposed by Shojania et al. 14 and subsequently adapted by Lau et al. 11 . Categories will be audit and feedback, case management, clinician education, clinician reminders, community engagement, continuous quality improvement, delivery site change, financial incentives for clinicians, financial incentives for patients, patient outreach, changes in care team personnel (team change), and changes to patient visit routine (visit structure change). Where appropriate, quality improvement strategies with a sufficient number of comparisons will be organized into subcategories, and meta-analyses will be conducted within each sub-category. Comparator group will be either usual care, non-vaccination intervention, or, when intervention group received additional strategy, whatever strategy the control group received. Randomised Controlled Trials (RCTs) and quasi RCTs, Studies need to be conducted among groups living in the community. The bibliographic software, EndNote, will be employed to organize, store, and manage all the citations. References retrieved from the four databases will be imported into Endnote. After removal of duplicate references, reviewers (PW and RW) will select studies for inclusion in the meta-analyses, first by screening of the titles and abstracts, and secondly, using full texts. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 11, 2021. ; https://doi.org/10.1101/2021.03.08.21253172 doi: medRxiv preprint We will attempt to obtain any references not available on-line or locally with the assistance of the University Library. Any differences in the selection of studies for inclusion will be resolved by discussion between reviewers and the other members of the research team if necessary. PW will extract data from each selected study. Study quality will be measured using a modified version of the Cochrane Risk of Bias (ROB) tool, 15 a 6-item questionnaire assessing the appropriateness of random sequence generation, allocation concealment, blinding of participants, personnel, and outcome assessors, data completeness, and other sources of biases. For quality assessment we summed individual scores. All studies reporting sufficient data to derive odds ratios and standard errors will be included in meta-analyses. Comparisons will be eligible to be included in the meta-analysis if the control group received usual care, or if the control intervention was focused towards non-vaccination behaviour, or if the intervention group received an additional strategy as well as whatever strategy was applied to both the intervention and control groups. When a given intervention can be classified into multiple quality improvement strategies, the number of subjects in the intervention group will divided between the strategies to avoid double-counting participants. Results from individual studies will be synthesized using random-effects models. Results will be reported overall, and by quality improvement strategy. Heterogeneity will be measured using the I 2 statistic. The number needed to target for vaccination will be calculated. Sensitivity analyses will be conducted to investigate any association between study quality (assessed by ROB scores) and reported effect sizes using meta-regression. Publication bias will be tested by generating funnel plots and applying Harbord's test. 16 Analyses will be performed using Stata v14.0 (StataCorp LP, College Station, TX, USA). Type of review -Systematic review and meta-analysis Health area of review -Public Health . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 11, 2021. ; https://doi.org/10.1101/2021.03.08.21253172 doi: medRxiv preprint It is intended to publish the results of this study in a peer-reviewed journal. Any amendments to this proposal will be documented and communicated in the final published manuscript. Influenza, Vaccination, Immunization, Vulnerable Populations, Risk Factors Ongoing is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 11, 2021 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 11, 2021 rate or rates or uptake or delivery or distribution or coverage or status:ti,ab,kw or "quality improvement" or qi or "quality management" or "case management" or "patient care" or interdisciplinary:ti,ab,kw or registr* or audit or education or reminder* or "self care" or "self management" or "medical record" or program* or intervention*:ti,ab,kw or "primary care":ti,ab,kw ( is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 11, 2021 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 11, 2021. ; https://doi.org/10.1101/2021.03.08.21253172 doi: medRxiv preprint tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study The annual impact of seasonal influenza in the US: measuring disease burden and costs Mortality associated with influenza and respiratory syncytial virus in the United States Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) Office of Disease Prevention and Health Promotion. Immunization and Infectious Diseases. Healthy People Record 16.5 million flu vaccines to protect Australians (media release) Centers for Disease Control and Prevention. Flu Vaccination Trends European Centre for Disease Prevention and Control. Seasonal Influenza Vaccination in Europe: Vaccination Recommendations and Coverage Rates in the EU Member States for Eight Influenza Seasons Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic reviews Centre for Reviews and Dissemination. Guidance notes for registering a systematic review protocol with PROSPERO Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis The Cochrane Collaboration's tool for assessing risk of bias in randomized trials